Femtech Global Market Report 2024

Femtech refers to technology supporting women's health through software, diagnostics, products, and services designed to meet female biological needs.

The main types of femtech encompass devices, software, services, and others. Devices in femtech represent a broad array of tools and products designed for improving women's health. This category includes wearable devices, treatment devices, and various other products tailored to women's health needs. Software in femtech is employed in female-oriented technological products that focus on women's wellness and healthcare. Services within femtech include medical services utilized in women's healthcare, which can involve therapy services dedicated to wellness and healthcare. Femtech serves various end-users, including direct-to-consumer platforms, hospitals, fertility clinics, surgical centers, and diagnostic centers. The applications of femtech cover a range of women's health areas, including reproductive health, pregnancy and nursing care, pelvic and uterine healthcare, general healthcare and wellness, among others.

The femtech market research report is one of a series of new reports from The Business Research Company that provides femtech market statistics, including femtech industry global market size, regional shares, competitors with a femtech market share, detailed femtech market segments, market trends and opportunities, and any further data you may need to thrive in the femtech industry. This femtech market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The femtech market size has grown rapidly in recent years. It will grow from $36.52 billion in 2023 to $41.97 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth observed in the historical period can be attributed to factors such as the increasing awareness of women's health, changing societal attitudes and taboos, a demand for personalized women's healthcare, a shift in women's health conversations, and a focus on empowerment and informed decision-making.

The femtech market size is expected to see rapid growth in the next few years. It will grow to $81.24 billion in 2028 at a compound annual growth rate (CAGR) of 18.0%. The anticipated growth in the forecast period can be attributed to factors such as evolving demographics and an aging population, the integration of digital health platforms, the rise of remote and telehealth services, a heightened focus on fertility and reproductive health, and an increased demand for preventive and wellness-oriented solutions in women's healthcare. Major trends expected in the forecast period include the development of AI-powered women's health apps, the use of wearable health devices specifically designed for women, the growth of mental health and wellness apps, the adoption of digital pelvic floor training, and increased investment in femtech startups.

The surge in digital healthcare is anticipated to drive the expansion of the femtech market. Digital healthcare technologies leverage connectivity, software, and sensors for various healthcare and related applications. In October 2022, a report from the Centers for Disease Control and Prevention, a US-based government agency, highlighted that 37.0% of adults had availed telemedicine services within the previous 12 months in 2021. Notably, women (42.0%) demonstrated a higher likelihood of utilizing telemedicine compared to men (31.7%). Furthermore, there was a positive correlation between age and telemedicine usage, with the percentage of adults engaging in telemedicine increasing with age. Specifically, usage rates escalated from 29.4% among adults aged 18-29 to 43.3% among adults aged 65 and above. Consequently, the positive consumer perception and substantial investments in digital health are expected to propel the growth of the femtech market.

The anticipated increase in healthcare spending is poised to bolster the growth of the femtech market in the foreseeable future. Healthcare spending encompasses the total expenditures made on healthcare-related goods and services by individuals, governments, and organizations within a specific region or country. The rise in healthcare spending serves as a catalyst for investment in research, development, and the adoption of innovative technologies within the femtech market, thereby improving access to cutting-edge products and services for women's health and well-being. For instance, as of March 2022, according to the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, the projected growth indicates that national health spending is expected to increase by an average of 5.1% annually between 2021 and 2030, reaching a total of nearly $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending will increase at a 7.2% annual pace, while Medicaid spending will rise at a 5.6% annual rate. Consequently, the escalating healthcare spending serves as a driving force behind the growth of the femtech market.

The femtech industry is witnessing a notable trend towards the adoption of advanced technology products. Companies are directing their efforts towards the development of products that not only deliver precise results but also minimize product handling time. An exemplar of this trend is evident in the initiatives of Lia, a US-based company. In 2021, Lia introduced the world's inaugural flushable and biodegradable pregnancy test device crafted from plant fibers, ensuring it is 100% free from plastic. Remarkably, this innovative product has the capacity to biodegrade in a mere ten weeks, showcasing a commitment to environmentally friendly practices within the femtech sector.

Leading companies in the femtech market are actively pursuing the development of cutting-edge technologies, including digital contraceptives, as part of their strategy to reach broader customer bases, drive sales, and boost revenue. A digital contraceptive is a medical device that utilizes self-tracked data and sophisticated algorithms to identify a menstruator's fertile window, effectively preventing pregnancy. For example, in March 2021, Clue, a Germany-based femtech company, announced the receipt of U.S. Food and Drug Administration (FDA) clearance for the launch of Clue Birth Control. The distinguishing feature of Clue's Birth Control is its comprehensive reliance on an all-digital contraceptive approach, leveraging period tracking data. By combining user-inputted menstrual cycle information with Clue's predictive algorithm, the feature accurately identifies high- or low-risk days for pregnancy. Users receive actionable recommendations to modify behaviors, including suggestions to abstain from sexual activity or employ additional contraception methods, such as condoms, on high-risk days. As users consistently input data, the algorithm refines its predictions, tailoring them over time and potentially reducing the high-risk window. It's noteworthy that Clue's birth control algorithm is rooted in the Dynamic Optimal Timing (DOT) algorithm, which was acquired and integrated to enhance the effectiveness of its contraceptive feature. This exemplifies a commitment to leveraging advanced technology to offer more personalized and effective solutions in the field of women's health.

In July 2022, FemTec Health, a health and beauty sciences company based in the United States, successfully acquired Ava Women for an undisclosed sum. This strategic acquisition is intended to facilitate the expansion of FemTech Health's product portfolio, particularly in the realm of reproductive health solutions. Ava Women, the Switzerland-based company being acquired, specializes in digital diagnostics and therapeutics focused on women's reproductive health.

Major companies operating in the femtech market report are Totohealth Inc., LifeSense Group, Lumenis Ltd., Maven Clinic, Kindbody Fertility & Women's Health, Flo Health Inc., Minvera Health Inc., Natural Cycles, NURX Inc., BioWink GmbH, Elvie Inc., Nuvo Group LLC, Lia Diagnostics Inc., Bloomlife Inc., Kasha Global Inc., Proov, Athena Feminine Technologies, Ava Science Inc., Joylux Inc., MedAnswers, OCON Healthcare LLC, Flyte by Pelvital, Inne Inc., Tia Health, Gennev, iSono Health Inc., OOVA Inc., Sera Prognostics Inc., Cora Health Inc., HeraMED Inc., Sustain Natural, LactApp Women's Health, Trak Fertility, Willow Pump Company, Yono Labs, Zava

North America was the largest region in the femtech market in 2023. The regions covered in the femtech market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the femtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The femtech market includes revenues earned by entities by providing period tracker, fertility tracking and solutions, menstruation products, prenatal and postnatal care products, and reproduction healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Femtech Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on femtech market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for femtech ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The femtech market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Devices; Software; Services; Other Types
• 2) By End Use: Direct-To-Consumer; Hospitals; Fertility Clinics; Surgical Centers; Diagnostic Centers
• 3) By Application: Reproductive Health; Pregnancy and Nursing Care; Pelvic and Uterine Healthcare; General Healthcare and Wellness; Other Applications
• Companies Mentioned: Totohealth Inc.; LifeSense Group; Lumenis Ltd.; Maven Clinic; Kindbody Fertility & Women's Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.